MedTrace Logo

Evaluating and Predicting Response to a Single Session Intervention for Self-Dislike

NCT04082052 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2020-10-06

No results posted yet for this study

Summary

The investigators are testing whether a single session online intervention for self-dislike decreases:

1. Fear of self-compassion from immediate pre to immediate post intervention
2. Self-hatred immediate pre to 1 month post-intervention
3. Individual depression symptoms immediate pre to 1 month post-intervention more than a placebo online single session intervention encouraging the disclosure of feelings in college students.

The investigators will also explicitly test whether the following variables are predictors, of at least the smallest variance predicted of interest, of response to treatment vs. placebo on self-hatred:
4. Pre intervention self-hatred score
5. Screening positive for clinical depression based on self-report
6. Immediate pre to post-intervention reduction in fear of self-compassion
7. The investigators will also assess whether any of the variance shared between the treatment and changes in individual depression symptoms immediately pre Intervention to 1 month post-intervention is statistically mediated by change in self-hatred from immediate pre intervention to 1 month post intervention

Conditions

  • Depressive Symptoms
  • Self-Appraisal

Interventions

BEHAVIORAL

Single Session Interventions

A single session intervention either active (for self-dislike) or placebo (feelings disclosure)

Sponsors & Collaborators

Principal Investigators

  • Jessica L Schleider, PhD · Stony Brook University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2021-05-31
Completion
2021-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082052 on ClinicalTrials.gov